GI Dysfunctions in Diabetic Gastroenteropathy, Their Relationships With Symptoms, and Effects of a GLP-1 Antagonist
Author(s) -
Subhankar Chakraborty,
Magnus Halland,
Duane D. Burton,
Anshuman Desai,
Bridget Neja,
Phillip A. Low,
Wolfgang Singer,
Michael Camilleri,
Alan R. Zinsmeister,
Adil E. Bharucha
Publication year - 2018
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2018-01623
Subject(s) - medicine , enteral administration , gastroenterology , asymptomatic , gastric emptying , diabetes mellitus , gastroparesis , placebo , antagonist , parenteral nutrition , endocrinology , stomach , alternative medicine , pathology , receptor
Delayed gastric emptying (GE) is common but often asymptomatic in diabetes. The relationship between symptoms, glycemia, and neurohormonal functions, including glucagonlike peptide 1 (GLP-1), are unclear.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom